Welcome to this special edition on Innosuisse funding. With record application volumes, securing grants demands a flawless strategy. Read on for critical updates on national calls and bilateral opportunities. Innosuisse is the perfect instrument to start applying your research to the market!

With a record 832 applications, Innosuisse is processing an unprecedented volume of requests. While funding is available, success requires strategy. Look directly at the data portal before applying to get an insight into success rates and craft an evidence-based proposal

As of April 1, 2026, Innosuisse updated its payment structure for newly approved projects to better align funding with actual progress. The new payment split is 35% / 35% / 30%, replacing the old 50/30/20 model. Please note that ongoing projects remain unaffected by this change.

This rolling call offers SMEs up to CHF 15’000 to fund feasibility studies or proof-of-concept validations with a Swiss research partner. It is the perfect, low-risk entry point to test your idea's market potential before launching a full-scale Innovation Project. Apply anytime.

This instrument funds science-based joint R&D to transform research into novel, market-ready products or services. Proposals with an industry partner can be submitted anytime. Continuous evaluation gives you the flexibility to align your submission perfectly with project readiness.

It is still possible to apply without an implementation partner. This track mainly supports early-stage innovation and proof-of-concept projects. Starting from 2027, the instrument will likely be integrated into a renewed BRIDGE programme. More details to follow in October.

Please note that bilateral calls will not be a strategic focus for Innosuisse in the foreseeable future. However, we urge you to seize current opening of Switzerland-South Korea Call. Act now to secure funding for your international joint innovation.

Targeting Biotech, Medtech, AI or Renewables? Form a joint consortium (1 CH & 1 KR company + 1 research institute) to co-develop market-ready solutions. Innosuisse funds up to 70% of Swiss R&D costs. Partner with Korean tech leaders to accelerate your international scale-up.

Eureka is the world's leading network for market-oriented R&D, connecting 45+ countries to fund commercial innovation. For SMEs and researchers, it's the ultimate springboard: it lowers development risks, opens global markets, and accelerates tech scale-up. Tap into this network

Targeting Biotech R&D? Form a joint consortium (min. 1 CH partner + 1 from a participating Eureka country) to develop market-ready solutions. Innosuisse funds up to 70% of Swiss costs. Secure your funding now before the strategic focus on bilateral programs definitively shifts.

Have a look at USI guide for Innosuisse Innovation Projects with an Implementation Partner, the main funding instrument offered by Innosuisse. Here you will find step-by-step instructions, examples, tips, and checklists to help you prepare a strong proposal.

Contact servizio.ricerca@usi.ch early on for support throughout the application process, e.g. for:
- eligibility check,
- budget preparation,
- reviewing applications,
- providing guidance on project design and documentation.